25 February 2013
A £113,000 grant has been awarded to UK researchers to drive prostate cancer research.
The money from Prostate Cancer UK will go to a team at the University of Southampton and is part of the charity's £2.7 million of pilot awards and project grants being distributed to universities and research hubs across the country.
Scientists at Southampton will investigate a new drug to target hormone activity in cancer tumours, a treatment they hope could control prostate cancer for a longer period.
The disease, which kills 10,000 men every year, is set to become the most common cancer in the UK by 2030, according to the British Journal of Cancer.
Speaking to the BBC, Southampton's Dr Simon Crabb said: "Over the last few years there have been major advances in therapies which target the activity of hormones in the prostate to treat advanced prostate cancer.
"Unfortunately, although these are usually initially very effective, it is common over time for the cancer to develop resistance, meaning there is a pressing need for improved treatments."
Posted by Edward Bartel
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare